Our website does not fully support your browser.

We've detected that you are using an older version of Internet Explorer. Your commerce experience may be limited. Please update your browser to Internet Explorer 11 or above.

We believe this site might serve you best:

United States

United States

Language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

pF9A CMV hRluc-neo Flexi® Vector Product Information

Instructions for Use of Product(s)

Literature # 9PIC936

The pF9A CMV hRluc-neo Flexi® Vector is designed for use with the Flexi® System, Entry/Transfer (Cat.#C8640) and the Flexi® System, Transfer (Cat.# C8820). The vector contains a CMV immediate early enhancer/promoter region plus a chimeric intron for mammalian expression, and a T7 promoter for in vitro expression of the protein-coding region. In addition, the vector contains a barnase gene for positive selection of the insert, an ampicillin-resistance gene for selection of the plasmid and unique SgfI and PmeI sites that allow easy insertion and transfer of the insert of interest. The pF9A CMV hRluc-neo Flexi® Vector also contains a unique neomycin-resistance gene fused with a humanized Renilla luciferase (hRluc) gene, under the control of the SV40 promoter, allowing long-term selection of transfected mammalian cells and the ability to monitor those selected cells using a Renilla luciferase assay. Transfection of the pF9A CMV hRluc-neo Flexi® Vector containing a protein-coding region into mammalian cells provides resistance to the antibiotic G-418 (Cat.# V7981 or V8091) and allows selection of transfectants.

Printed in USA. Revised 9/16